Jones RL - Search Results

1

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.

Tan DS, Marchió C, Jones RL, Savage K, Smith IE, Dowsett M, Reis-Filho JS. Tan DS, et al. Among authors: jones rl. Breast Cancer Res Treat. 2008 Sep;111(1):27-44. doi: 10.1007/s10549-007-9756-8. Epub 2007 Oct 6. Breast Cancer Res Treat. 2008. PMID: 17922188

2

Efficacy and safety of trastuzumab.

Jones RL, Smith IE. Jones RL, et al. Expert Opin Drug Saf. 2004 Jul;3(4):317-27. doi: 10.1517/14740338.3.4.317. Expert Opin Drug Saf. 2004. PMID: 15268649 Review.

3

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma.

Jones RL, Lakhani SR, Ring AE, Ashley S, Walsh G, Smith IE. Jones RL, et al. Br J Cancer. 2006 Feb 13;94(3):358-62. doi: 10.1038/sj.bjc.6602950. Br J Cancer. 2006. PMID: 16421590 Free PMC article.

4

Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.

Reis-Filho JS, Steele D, Di Palma S, Jones RL, Savage K, James M, Milanezi F, Schmitt FC, Ashworth A. Reis-Filho JS, et al. Among authors: jones rl. Mod Pathol. 2006 Feb;19(2):307-19. doi: 10.1038/modpathol.3800542. Mod Pathol. 2006. PMID: 16424897 Free article.

5

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.

Reis-Filho JS, Savage K, Lambros MB, James M, Steele D, Jones RL, Dowsett M. Reis-Filho JS, et al. Among authors: jones rl. Mod Pathol. 2006 Jul;19(7):999-1009. doi: 10.1038/modpathol.3800621. Epub 2006 Apr 28. Mod Pathol. 2006. PMID: 16648863 Free article.

6

Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response.

Jones RL, Smith IE. Jones RL, et al. Lancet Oncol. 2006 Oct;7(10):869-74. doi: 10.1016/S1470-2045(06)70906-8. Lancet Oncol. 2006. PMID: 17012049

7

Anthracycline cardiotoxicity.

Jones RL, Swanton C, Ewer MS. Jones RL, et al. Expert Opin Drug Saf. 2006 Nov;5(6):791-809. doi: 10.1517/14740338.5.6.791. Expert Opin Drug Saf. 2006. PMID: 17044806 Review.

8

MYC amplification in breast cancer: a chromogenic in situ hybridisation study.

Rodriguez-Pinilla SM, Jones RL, Lambros MB, Arriola E, Savage K, James M, Pinder SE, Reis-Filho JS. Rodriguez-Pinilla SM, et al. Among authors: jones rl. J Clin Pathol. 2007 Sep;60(9):1017-23. doi: 10.1136/jcp.2006.043869. Epub 2006 Dec 8. J Clin Pathol. 2007. PMID: 17158641 Free PMC article.

9

Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis.

Savage K, Lambros MB, Robertson D, Jones RL, Jones C, Mackay A, James M, Hornick JL, Pereira EM, Milanezi F, Fletcher CD, Schmitt FC, Ashworth A, Reis-Filho JS. Savage K, et al. Among authors: jones c, jones rl. Clin Cancer Res. 2007 Jan 1;13(1):90-101. doi: 10.1158/1078-0432.CCR-06-1371. Clin Cancer Res. 2007. PMID: 17200343

10

Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer.

Arriola E, Rodriguez-Pinilla SM, Lambros MB, Jones RL, James M, Savage K, Smith IE, Dowsett M, Reis-Filho JS. Arriola E, et al. Among authors: jones rl. Breast Cancer Res Treat. 2007 Dec;106(2):181-9. doi: 10.1007/s10549-006-9492-5. Epub 2007 Jan 27. Breast Cancer Res Treat. 2007. PMID: 17260090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,358 results

Search Page